Yuyu Pharma introduces enhanced ERP system

SEOUL, South Korea, March 31, 2020 /PRNewswire/ — Yuyu Pharma (CEO Robert Wonsang Yu, KRX 000220) introduced a new Enterprise Resource Planning (ERP) system to identify real-time management conditions and enhance system management for more efficient decision-making.

The new ERP system took more than 1 year to develop. The focus was integrating the ERP systems of not only Yuyu Pharma, but with those of Yuyu’s affiliates such as Yuyu Teijin Medicare.

The new ERP system integrates the information from Sales, Manufacturing, Purchasing, Quality Control, Finance, and Human Resources into real-time links, allowing a more effective cost, profit analysis. Details of each activity, such as clinical trials, post-marketing surveys, and academic symposiums are subdivided, and the expenses incurred by each activity are automatically reconciled with details of use of funds. This makes it easier to manage and report item by classifications.

“The ERP system allows for more insightful and secure methods for data management. We will be able to look at how we are managing the entire company process and leverage that to make better decisions. We will continue to upgrade our system to be competitive in today’s environment,” said CEO Robert Yu.

About Yuyu Pharma

Yuyu Pharma(KRX: 000220) is a pharmaceutical company founded in 1941. The company manufactures, distributes, and does marketing for pharmaceutical products, medical devices, and medical foods in South Korea and Southeast Asia. Currently, Yuyu Pharma is focusing on developing new drugs for treating enlarged prostates and dry eye syndrome.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/yuyu-pharma-introduces-enhanced-erp-system-301031718.html

SOURCE Yuyu Pharma

Staff

Recent Posts

Castle Biosciences Announces Updates to its Board of Directors

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that…

5 hours ago

Akanda Corp. Announces Closing of Underwritten Public Offering

London, United Kingdom--(Newsfile Corp. - March 27, 2024) - On March 24, 2024, Akanda Corp.…

5 hours ago

Dermata to Present at the Emerging Growth Conference on April 3, 2024

- Dermata to provide a corporate update followed by a live question and answer session…

5 hours ago

CorDx Receives Emergency Use Authorization (EUA) for 10-Min Flu A/B & COVID-19 Test

FDA Grants CorDx Emergency Use Authorization for Multi-Target Rapid Test for Flu A/B & COVID-19SAN…

8 hours ago

Greenway Health and DrFirst Partner to Improve Medication Adherence and Improve Patient Outcomes through Technology

TAMPA, Fla., March 27, 2024 /PRNewswire/ -- Greenway Health, a leading health information technology services provider, announced its strategic…

10 hours ago

NextGen Healthcare Named to Newsweek List of America’s Most Trustworthy Companies for Third Year in a Row

List Based on an Independent Survey of 25,000 U.S. ResidentsREMOTE-FIRST COMPANY/NEW YORK--(BUSINESS WIRE)--#NextGenHealthcare--NextGen Healthcare, a…

11 hours ago